Clinuvel Pharmaceuticals (CUV.AU) Q3 2026 Earnings

Aug 26Confirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
0.19
0.29
0.39
0.48

Details

Expected EPS
0.4822756040460013
Actual EPS
0.45269171864557806
Surprise EPS
-0.03
Surprise Percent
-6.13%

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦CUV.AU⁩) has reported earnings of ⁦0.45269171864557806⁩ per share for ⁦Q3 2026⁩.

0 Comments

Share your thoughts